Latest Neurogenesis Stories

2011-06-07 08:41:00

ROCKVILLE, Md., June 7, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has signed an exclusive agency licensing agreement with Summit Pharmaceuticals International Corporation, of Tokyo, Japan (SPI), a wholly owned subsidiary of Sumitomo Corporation Group.

2011-05-12 00:00:46

Hippocampal stems cells for use in neuroscience and cytotoxicity testing. Branford, CT (PRWEB) May 11, 2011 GigaCyte, LLC., a leading provider of human stem cell-based products and preclinical contract research services, headquartered in Branford, Connecticut USA, announced the launch of human hippocampal stem cells for use in neuroscience and cytotoxicity testing.

2011-04-26 14:21:54

Abundant precursor cells can become many types of neurons without introducing tumor risk.

2011-04-20 12:05:00

ROCKVILLE, Md., April 20, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced it has signed a Memorandum of Understanding with BaYi Brain Hospital in Beijing, China.

2011-04-12 11:10:00

British scientists using human stem cells claim to have discovered how antidepressants create new brain cells, helping drug researchers develop more efficient medicines to fight depression.

2011-03-25 12:03:15

A group of scientists at Marshall University is conducting research that may someday lead to new treatments for repair of the central nervous system.

2011-03-10 15:40:00

Two studies published by an interdisciplinary team of Hong Kong researchers in the current special issue of Cell Transplantation (20:1), now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/ , link the regrowth of key adult brain cells (neurogenesis) in two critical areas of the brain to both the benefits of exercise as a stress reducer and also to sexual behavior and reproductive issues.

2011-03-08 07:46:31

Northwestern Medicine researchers for the first time have transformed a human embryonic stem cell into a critical type of neuron that dies early in Alzheimer's disease and is a major cause of memory loss.

2011-03-01 06:00:00

ROCKVILLE, Md., March 1, 2011 /PRNewswire/ -- Neuralstem, Inc. (Amex: CUR) announced that the first subject was dosed yesterday in a Phase Ia trial to evaluate the safety of its drug, NSI-189, which is being developed for the treatment of major depressive disorder and other psychiatric indications.

2011-02-09 11:56:00

ROCKVILLE, Md., Feb. 9, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that the U.S.

Word of the Day
  • A volcanic mudflow.
The word 'lahar' comes from Javanese.